RC 891
Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
LISOCABTAGENE MARALEUCEL 70000000 CELLS/ML IV SUSP
Maple Grove, MN
See all hospitals reporting RC 891 →Price type
Fairview Maple Grove Surgery Center’s median price of $882.1k is 17157% above the median hospital's median price ($5.1k), higher than 69% of the 432 hospitals reporting RC 891. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.
Negotiated rates from the hospital’s own file: 5 payers, 8 plan rates. A facility fee, a professional fee, a per diem and a case rate are different bills, so each is listed on its own. Open a payer to see it across hospitals.
Filter by billing methodology
Filter by billing class
| # | |||||||
|---|---|---|---|---|---|---|---|
| 1 | Blue Cross Blue Shield medicaid fee schedule · outpatient | $431.6k | $417.6k | $40.9k | 10% | — | $338.0k – $455.3k |
| 2 | Blue Cross Blue Shield federal fee schedule · outpatient | $424k | $455.4k | $52.0k | 11% | — | $424k – $557.8k |
| 3 | Blue Cross Blue Shield commercial fee schedule · outpatient | $431.6k | $463.6k | $52.9k | 11% | — | $431.6k – $567.9k |
| 4 | Ucare ifp percent of total billed charges · outpatientfrom % of charges | $890.4k | $789.9k | $300.1k | 38% | — | $956 – $954.9k |
| 5 | Ucare ifp with fairview percent of total billed charges · outpatientfrom % of charges | $890.4k | $789.9k | $300.1k | 38% | — | $956 – $954.9k |
| 6 | Cigna commercial fee schedule · outpatient | $873.3k | $848.4k | $84.0k | 10% | — | $748.7k – $1018.3k |
| 7 | First Health commercial percent of total billed charges · outpatientfrom % of charges | $1460.2k | $1295.4k | $492.1k | 38% | — | $1.6k – $1566.0k |
| 8 | MultiPlan commercial percent of total billed charges · outpatientfrom % of charges | $1513.7k | $1342.8k | $510.1k | 38% | — | $1.6k – $1623.3k |
Last updated: May 18, 2026
See Specially processed FDA-approved cell therapy drug pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.